
The R1,650-crore Surya Pharma is set to make its foray into the cash-and-carry business in the next three-four months.

The R1,650-crore Surya Pharma is set to make its foray into the cash-and-carry business in the next three-four months.

With the next WHO inspection of Indian drug regulator due in March 2012, WHO country-head, India.

The profits before tax of domestic drug firms could shrink by over one-fifth if the new pharma pricing policy is…

The wild chase to speculate on the penalty that Ranbaxy Labs would have to shell out to resolve its ongoing…

The department of pharmaceuticals plans to resurrect its struggling dream project ? the Jan Aushadhi Scheme ? by pumping in…

To attain the goal of ?health for all? by 2022, a high-powered panel constituted by the prime minister has prescribed…

The managing director of Pfizer India, Kewal Handa shares his reservations on the country?s emerging pharma policy landscape in an…

The top twenty pharma companies by domestic revenue would absorb 61% of the total envisaged loss of around R1,485 crore…

Pharma major Lupin aims to crack the $96-billion pharma market of Japan, the second largest globally, through its second acquisition…

Three ports and airports ? Mormugao port in Goa and the airports in Goa and Bangalore ? are set to…

It may sound unusual for hospital chains to plan their expansion along train routes, but Analjit Singh?s Max Healthcare has…

The jinxed journey of Ranbaxy Labs to launch the generic version of the blockbuster drug globally ? Lipitor ? continues,…

The choice for family planning may get a boost as the government is considering removing the ban on injectable contraceptives.

The government plans to quantify the economic losses the country suffers by compromising on food safety.

Loss to the R58,000-crore domestic pharma industry may not exceed R1,000 crore if the latest national pharma pricing policy draft…

Top Indian drug firms are way ahead of their multinational peers when it comes to launching new drugs in the…

India?s largest drugmaker by sales, Ranbaxy Labs, is in race with the Chinese telecom equipment-maker ZTE to acquire Nokia?s factory…

A free medicine distribution scheme started by the Rajasthan government early this month is being viewed as a threat to…